Sorry, you need to enable JavaScript to visit this website.

All announcements

Announcement Date

Dear HCP Letter: Communication of new safety information for XELJANZ (tofacitinib)

March 1, 2019

Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis

February 20, 2019

Introducing Partner4Better


We are pleased to introduce a new initiative by Pfizer Medical Information called Partner 4 Better. This program provides educational content to support evidence-based decision making and the responsible use of medicines.
November 6, 2018

Exact Sciences and Pfizer Enter into a U.S. Agreement for CologuardĀ®


On August 22, 2018, Exact Sciences Corp. and Pfizer Inc. announced an agreement to co-promote Cologuard, the FDA-approved non-invasive stool DNA screening test for colorectal cancer. Pfizer joins Exact Sciences' colleagues in reaching both physicians and health systems and also actively participates in extending and deepening the Cologuard development. For further medical information, please call Exact Sciences Provider Support Line 1-844-870-8870
October 8, 2018